Brenda J. Gehrke

FDA Approval: Blinatumomab

Donna Przepiorka, Chia‐Wen Ko, Albert Deisseroth et al. · Clinical Cancer Research · 2015 · 364 citations

Medicine, Hematology, Oncology +17

Environmental enrichment decreases intravenous amphetamine self-administration in rats: dose-response functions for fixed- and progressive-ratio schedules

T. Green, Brenda J. Gehrke, Michael T. Bardo · Psychopharmacology · 2002 · 172 citations

Medicine, Behavioral Sciences, Pharmacology +17

Vandetanib for the Treatment of Symptomatic or Progressive Medullary Thyroid Cancer in Patients with Unresectable Locally Advanced or Metastatic Disease: U.S. Food and Drug Administration Drug Approval Summary

Katherine A. Thornton, Geoffrey Kim, V. Ellen Maher et al. · Clinical Cancer Research · 2012 · 147 citations

Medicine, Oncology, Pharmacology +7

U.S. Food and Drug Administration Approval: Crizotinib for Treatment of Advanced or Metastatic Non–Small Cell Lung Cancer That Is Anaplastic Lymphoma Kinase Positive

Shakun Malik, V. Ellen Maher, Karen E. Bijwaard et al. · Clinical Cancer Research · 2014 · 139 citations

Medicine, Oncology, Pharmacology +14

Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum

Brenda J. Gehrke, Vladimir I. Chefer, Toni S. Shippenberg · Psychopharmacology · 2008 · 76 citations

Life Sciences, Neuroscience, Pharmacology +13